| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Medincell Better Medicine For All Better Medicine for All MedinCell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. … Type: | 4 | 1 | 2 | 146 |
 | Biological E. Limited Celebrating Life Everyday Biological E. Limited (BE), the first private sector biological products company in India and the first pharmaceuticals company in South India was established in 1953. Originally incorporated as Biological Products Private Limited, and launched by Dr. Vijay Kumar Datla, today, BE is a globally recognised vaccine manufacturer and has supplied over 2 Billion Doses of Vaccines till date all over the world. BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz. UNICEF, PAHO, many global markets, and in India to the National Immunization Program, various State Governments, PSUs, Indian Armed Forces and the … Type: | 4 | 2 | 0 | 3,489 |
 | Bausch + Lomb We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, we have a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Eye health, ophthalmic pharmaceuticals, ophthalmic surgical products, and contact lens … Type: | 4 | 3 | 1 | 8,527 |
 | TOPRA - The Organisation for Professionals in Regulatory Affairs Enabling and promoting excellence in the healthcare regulatory profession TOPRA, The Organisation for Professionals in Regulatory Affairs, is a non-profit, non-political organisation which seeks to advance the status of the regulatory profession through education and provision of information to its members. Our current membership is drawn from over 50 countries, and members worldwide are actively involved in delivering the services needed by busy regulatory specialists. Members are drawn from industry, regulatory agencies and the consultancy community, and work in all sectors including medical technologies, biotech, borderline products and pharmaceuticals. Training, Events, Information Services and Networking, regulatory affairs, pharmaceutical industry, veterinary … Type: | 4 | 0 | 4 | 127 |
 | Nephron Pharmaceuticals Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications. NPC sells to many classes of trade, including, but not limited to, hospitals, pharmacies, long term care facilities, home care companies and mail order pharmacies. These medications are used in the treatment of asthma and COPD. Manufacturer of generic respiratory medications and Contract manufacturing blow-fill-seal medications Type: | 4 | 0 | 0 | 838 |
 | Daiichi Sankyo Europe GmbH Passion for Innovation. Compassion for Patients. Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. In Europe, we want to become the benchmark for customer centricity in the areas we work in and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - … Type: | 4 | 1 | 1 | 900 |
 | Abdi Ibrahim Pharmaceuticals İşimiz İyileştirmek Abdi İbrahim, Turkish pharmaceutical industry leader, was founded in 1912 in Küçükmustafapaşa, Istanbul at a small pharmacy, by Pharmacist Abdi Nadir İbrahim Bey who had started the “healing” journey. Abdi İbrahim has the largest product portfolio in the sector, with nearly 250 brands and more than 500 products which it develops itself as well as working with 30 licensors. With a powerful vision, dynamic structure and contemporary outlook, Abdi İbrahim has been the leader of Turkey’s Pharmaceutical Industry since 2002. Today, Abdi İbrahim, which operates in 17 countries outside Turkey, exports to more than 70 countries ranging from … Type: | 4 | 2 | 0 | 4,384 |
 | Diaceutics PLC Better Testing, Better Treatment At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®. DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Personalized medicine planning and corporate strategy, Comprehensive commercial planning in personalized medicine, Optimizing return on investment in personalized medicine, Leveraging diagnostics to enhance value in personalized medicine, Understanding … Type: | 4 | 2 | 1 | 200 |
 |  Shorla Oncology At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. At Shorla Oncology we develop and commercialize innovative oncology drugs for women’s and pediatric cancers. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments. Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care … Type: | 4 | 2 | 1 | 25 |
 | Laboratoire Dielen [Automatic translation follows] The new generation of pharmacy advice products 💊 Since 1978, Laboratoire Dielen has developed and marketed natural health products recognized by pharmacists and doctors. The Dielen Laboratory offers a range of 11 food supplements whose health benefits have been clinically demonstrated. Type: | 4 | 2 | 3 | 31 |
 | Kern Pharma [Automatic translation follows] Our mission for 25 years is to take care of people's health with an eye toward the future and innovation. Kern Pharma is a privately held pharmaceutical company that belongs to the Indukern Group and has its own commercial activities in the ethical and hospital field with both generic and branded products. Furthermore it is a reliable partner for contract manufacturing activities for important players of the pharmaceutical market. Kern Pharma is the pharmaceutical company of the Indukern Group. It bases its activity around two strategic business axes: - The development, manufacturing and marketing of pharmaceutical products … Type: | 4 | 0 | 0 | 834 |
 | Verband Forschender Arzneimittelhersteller e.V. (VFA) [Automatic translation follows] Research is Germany's best medicine. We are the vfa, the association of research-based drug manufacturers. We represent the interests of 48 leading global member companies and over 100 subsidiaries and sister companies in health, research and economic policy. This means: We represent the interests of 90,000 employees in Germany. The vfa therefore represents more than two thirds of the entire German pharmaceutical market. Our goal: We want to maintain Germany's high level of research and drug therapies. To this end, the German pharmaceutical industry is investing almost 8 billion euros (2020) in drug development. As vfa we … Type: | 4 | 0 | 1 | 44 |
 | INFARMA - The Employers’ Union of Innovative Pharmaceutical Companies INFARMA represents 24 leading companies in the innovative pharmaceutical sector The Employers’ Union of Innovative Pharmaceutical Companies, INFARMA, represents 24 leading companies in the pharmaceutical sector operating in Poland that conduct research & development and produce innovative medicines. INFARMA is a member of EFPIA, the Employers of Poland, and the Polish Chamber of Commerce. Type: | 4 | 0 | 4 | 17 |
 |  Karyopharm Therapeutics Inc. Discovers, develops and commercializes novel, life-changing cancer therapies in disease areas with high unmet need. Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL). oncology, pharmaceutical, biotech, … Type: | 4 | 0 | 1 | 402 |
 | Crystal Pharmatech A Leading CRO/CDMO for Solid Form & Formulation, Advancing Your PCC to Phase I and Beyond with First-Time-Right Approach Established in 2010, Crystal Pharmatech is a specialized CRO/CDMO, excelling in crystal form and formulation services. Our exceptional track record includes supporting 1,000 clients and collaborating on over 2,000 compounds, showcasing our expertise in solid-state research, crystallization, pre-formulation, formulation development, and manufacturing. With a global presence encompassing three strategically located R&D centers in Suzhou (China), New Jersey (USA), and Toronto (Canada), we are powered by a skilled team of around 250 professionals. As a leader in both conventional and enabling formulation … Type: | 4 | 0 | 4 | 70 |
 | EVERSANA EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com. Regulatory, Management & Specialty Consulting, Research & Insights, Global Pricing Strategies, Patient, Payer & Provider Marketing Services, Field Medical, Market Access & Sales , Global … Type: | 4 | 1 | 0 | 4,112 |
 | Novartis España [Automatic translation follows] At Novartis we work to continue innovating in health and changing the practice of medicine. We reimagine medicine. Novartis is reimagining medicine to improve and prolong people's lives. As a leading global medicines development company, we use science-based innovation and digital technologies to create transformative treatments in areas of significant medical need. In our mission to discover new medicines, we are among the best companies in the world in terms of investment in research and development. Novartis products reach more than 800 million people globally and we strive to find innovative solutions to expand access to our … Type: | 4 | 1 | 3 | 317 |
 | IgniteData Shaping the Future of Clinical Trial Data IgniteData’s Archer technology is transforming the way hospitals and research sites transfer data for clinical trials. EHR-to-EDC data transfer provides fast, accurate patient data for clinical studies, significantly reducing the requirement for laborious data transcription and source data verification (SDV). pharmaceutical, NHS, Electronic Health Records, healthcare data, Clinical Research, Clinical Trials, Clinical Studies, Site Data Verification, biopharma, biopharmaceutical, EHR, EMR, EHR2EDC, interoperability, DigiHealth, medtech, software, life science, healthcare, eClinical, and TrialTech Type: | 4 | 0 | 3 | 15 |
 | MannKind Corporation Our mission is to give people control of their health and the freedom to live life. MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where … Type: | 4 | 0 | 3 | 539 |
 | Mitsubishi Tanabe Pharma America We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, … Type: | 4 | 0 | 1 | 239 |
 | British Generic Manufacturers Association (BGMA) Better Access, Better Health The British Generic Manufacturers Association (BGMA) represents the interests of UK-based manufacturers and suppliers of generic medicines and promotes the development and understanding of the generic medicines industry in the United Kingdom. Generic medicines contain the same active ingredient and are as effective as their equivalent brands. Type: | 4 | 0 | 4 | 11 |
 | American Association of Pharmaceutical Scientists (AAPS) | @aapscomms AAPS is an association that advances the capacity of pharmaceutical scientists to develop therapies that improve health. The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 9,000 members employed in academia, industry, government, and other research institutes worldwide. Founded in 1986, AAPS advances the capacity of pharmaceutical scientists to develop products and therapies that improve global health. Visit www.aaps.org today. AAPS VISION Advancing the pharmaceutical sciences to drive prevention and cures. AAPS MISSION AAPS advances the capacity of pharmaceutical scientists to develop products and therapies that improve global health. pharmaceutical sciences, continuing education, professional development, … Type: | 5 | 1 | 2 | 293 |
 | Lif - Lægemiddelindustriforeningen The Danish Association of the Pharmaceutical Industry. Den danske brancheorganisation for lægemiddelindustrien. Lif is the Danish Association of the Pharmaceutical Industry. Our member companies are behind the majority of the industrial medical research carried out in Denmark. Lif works for the pharmaceutical industry to be perceived as a responsible partner that makes a valuable contribution to society. Lif's mission is to work to ensure that the pharmaceutical industry has the best possible conditions to research, develop, market, distribute and provide information on medicinal products so as to ensure that patients have extensive and rapid access to the best medical treatment. Type: | 5 | 0 | 5 | 53 |
 | Signant Health The Evidence Generation Company Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 20 years, over 400 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, eConsent, RTSM, supply chain management, and data quality analytics. Learn more at www.signanthealth.com. clinical trial software, eCOA, eConsent, IRT, Clinical Supply Optimization, Patient Engagement, Rater Training, Data Quality, … Type: | 5 | 2 | 3 | 2,072 |
 | Phizzle Bringing the power of automation to pharmaceutical manufacturing Phizzle is a market leader in automating and digitizing scientific lab instruments used in pharma and other clean manufacturing environments. The vast majority of these instruments are not connected to a cloud based solution to harmonize or digitize their data. Phizzle is a first-mover in this market with a patented IoT solution that can remotely operate multiple types and vendors of lab instruments from the cloud. Phizzle has a recurring revenue contract with a Fortune 75 company and is FDA-compliant in its use case, which is the first of its kind. Contact … Type: | 5 | 1 | 5 | 22 |
 | ABL GMP PURE-PLAY VIRAL VECTOR CDMO. From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< … Type: | 5 | 5 | 2 | 505 |
 | Medtech & Pharma Platform Association An Association focused on combined products The MPP Association aims to enhance interactions between pharma, medtech and tech industries, in order to promote product development and innovation. This is achieved by creating a forum to exchange knowledge and facilitate collaboration in technology- and regulatory-related areas. The Association also engages in European policy work to ensure that the interests of key stakeholders and MPP members are conveyed in the European regulatory and policy framework. The MPP Association organizes the international annual conference, which has gained increasing interest since its initiation in 2014 and continues to attract key stakeholders from the pharma, … Type: | 5 | 0 | 5 | 5 |
 | Molecule AG A decentralised biotech protocol porting intellectual property into web3 and launching biotech DAOs We propel science from lab to life, fueled by a community committed to human progress. blockchain, pharma, health, science, biotech, and Token Bonding Curves Type: | 5 | 0 | 2 | 33 |
 | Cenexi Creating innovative partnerships | CDMO Cenexi, a French Contract Development and Manufacturing Organization with its 1,500 employees and 200 million € of turnover, is experiencing a steady growth with its four manufacturing sites (Fontenay-sous-Bois, Osny and Hérouville-Saint-Clair in France, Braine-l'Alleud in Belgium) and one development center for New Product Introduction. Created in 2004, the Cenexi Group is positioned on the very active international market for medicinal products with a major therapeutic indication, drawing on its spirit of innovation and its extensive expertise, both in manufacturing and in product development The arrival of the new top management team induces a new … Type: | 5 | 0 | 5 | 933 |
 | RCTs Partenaire de l’innovation médicale RCTs is a French and International Full-Service CRO with more than 30 years of experience and over 700 projects conducted: clinical studies from phase I to phase IV, real-life or public health impact studies, medical and administrative assessments of SNDS (National Health Data System) databases, in various therapeutic areas (oncology, diabetes, cardiology, rheumatology, infectious diseases, central nervous system, vaccines...), for drug and medical device manufacturers, as well as for academic sponsors, institutions, learned societies and patient associations. Besides, RCTs has an expertise in clinical evaluations (CEP and CER) and regulatory consulting for medical devices. It is … Type: | 5 | 0 | 5 | 44 |
 | CLINACT Contract Research Organisation CLINACT, a MultiHealth Group company, is a Contract Research Organisation (CRO) assisting you in your health products development: pharmaceutical, medical devices, biotechnology, cosmetics, nutrition... With more than 20 years of experience, CLINACT provides its expertise for large range of innovative services: - Clinical operations - Biometrics - Medical and regulatory affairs - Pharmacovigilance, medical device vigilance and other vigilances - E-tools : Clinfile - Outsourcing and recruting : TempoPHARMA - Professional Training : FORMATIS This range of services fully covers industrials or academic organisations' requirements. As a MultiHealth company, CLINACT can also provide specific services withtout any … Type: | 5 | 0 | 5 | 118 |
 | CARBOGEN AMCIS BRINGING YOUR SCIENCE TO LIFE CARBOGEN AMCIS leverages its world-class chemistry skills to provide seamless drug substance, drug products development and commercialization services for leading pharmaceutical and biopharmaceutical companies. We help customers create a better world by becoming the partner of choice thanks to our innovative solutions. We offer an array of integrated and customized services operating in a fully cGMP-compliant infrastructure, including dedicated Highly Potent API facilities and a clean room for Antibody Drug Conjugates. Beyond our services, we also provide high-quality Cholesterol and Vitamin D analogs. CARBOGEN AMCIS is owned by Dishman Carbogen Amcis Limited, (India). Learn more … Type: | 5 | 3 | 1 | 700 |
 | Evotec #researchneverstops Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients. Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing. We aspire to contribute data-driven disease understanding and … Type: | 5 | 2 | 3 | 4,958 |
 | Phlexglobal - a PharmaLex company now part of Cencora Master your Digital Agenda with Clinical and Regulatory Solutions from Phlexglobal. Phlexglobal is the leading technology and services organization for clinical and regulatory matters with a focus on helping clients to master their digital agenda via proven AI solutions. Phlexglobal combines software and leading expert services to offer a unique solutions portfolio with easy to achieve automation via data generation that lifts organizations to a new level of effectiveness. PhlexTMF, the company’s Trial Master File software, and Regulatory Solutions including PhlexSubmission for eCTD and CTD, PhlexIDMP, PhlexEVMPD, and PhlexRIM are considered highly innovative in the industry for their out of … Type: | 5 | 0 | 5 | 368 |
 | ProductLife Group ProductLife Group’s mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions. Since almost 30 years, PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 130 countries. It provides consulting and outsourcing services in the areas of regulatory affairs, quality and compliance, vigilances and medical information, covering both established products and innovative therapeutics & diagnostics. With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency. Data Management, … Type: | 5 | 2 | 3 | 1,124 |
 | Calliditas Therapeutics Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products. Type: | 5 | 2 | 0 | 228 |
 | LES PHARMACIENS ASSOCIES [Automatic translation follows] Together, let’s increase our chances of success! The Les Pharmaciens Associés network has developed a complete program to develop the pharmacist's pharmacy. Becoming stronger collectively to be stronger individually, this is the philosophy of our network, Les Pharmaciens Associés. Type: | 5 | 0 | 5 | 16 |
 | AESGP Empowering Self-Care in Europe Established in 1964, the Association of the European Self-Care Industry (AESGP) represents the manufacturers of non-prescription medicines, food supplements and self-care medical devices (an area also referred to as consumer healthcare products). Our mission is to advance responsible self-care, enabling citizens to take better care of their health needs, and to contribute to the sustainability of European healthcare systems. OTC, Substance based MD, Non-prescription medicines, Pharmaceutical, Self-care, and Food supplement Type: | 5 | 0 | 5 | 21 |
 | Himalaya Wellness Company In 1930, a young visionary by the name of Mr. M. Manal foresaw the benefits of herbal remedies while riding through the forests surrounding dehradun. After diligently researching the science of the traditional field of Ayurveda, he decided to dedicate his life creating products that would improve millions of lives across the world. Today, with a history spanning more than nine decades in herbal research, Himalaya has positioned itself as a brand that cares about not only enriching people’s lives but also safeguarding the environment. With their “head-to-heel” range of products, Himalaya aims to provide a holistic solution to everyday … Type: | 5 | 0 | 2 | 6,130 |
 | Suvoda IRT, eConsent, and eCOA solutions to help you wisely guide novel science through complex clinical trials Suvoda is a global clinical trial technology company that provides IRT, eConsent and eCOA software and services for complex, life-sustaining studies in therapeutic areas like oncology, central nervous system, and rare disease. Clinical trial management, Interactive response technology, Subject randomization, Trial supply management, IWRS, IRT, Interactive Web Response System, Clinical Supplies, Patient Logistics, and Clinical Supply Logistics Type: | 5 | 1 | 4 | 934 |
 | STRATEGIQUAL SAS Strategiqual is a consulting company located in the center of Paris and operating in Europe, with extensive experience in Europe and the US. Its area of expertise covers pharmaceutical products, medical devices and biotechnology. Strategiqual has in-house expertise in the areas of regulatory affairs, strategic plans, gap analysis, risk analysis, audits, product compliance, quality management systems implementation. Specialties : - Systems approach for designing Quality Management Systems (pharmaceutical products, medical devices, biotechnology) - Drug device combinations (the so called "rule 13" of directive 93/42/CEE) - Innovative medical devices: quality and regulatory approaches; Accès au marché Europe (DM), Accès au marché … Type: | 5 | 5 | 1 | 53 |
 | Red Mujeres Farma [Automatic translation follows] Network of Women in the pharmaceutical industry, with the aim of empowering, making visible and promoting female talent. Red Mujeres Farma is a community for professionals in the pharmaceutical and related sectors, with the aim of empowering, making visible and promoting female talent. We want to give a voice to all women in the sector, providing spaces to share ideas and initiatives. Type: | 5 | 1 | 5 | 4 |
 |  LEO Innovation Lab - LEO Ventures A/S Innovating to improve the lives of people living with chronic skin conditions LEO Innovation Lab is an independent unit, established by LEO Pharma as part of a long-term strategic decision to focus on patient needs. We nurture companies to lead the digital health revolution with the single goal of improving the quality of life for people living with chronic skin conditions. Located in Copenhagen, with hubs around the globe, the Innovation Lab creates companies and invests in ventures with disruptive potential in the healthcare arena. healthcare, psoriasis, ehealth, technology, skin conditions, patient-centric, artificial intelligence, health technology, machine learning, clinical trials, … Type: | 6 | 2 | 0 | 8 |
 | DCAT (Drug, Chemical & Associated Technologies Association) The Premier Business Development Association for the Global Bio/Pharmaceutical Manufacturing Value Chain Founded in 1890, the Drug, Chemical & Associated Technologies Association, Inc. (DCAT) is a not-for-profit, corporate member-supported, and volunteer-led global business development association for companies engaged in the Bio/Pharmaceutical manufacturing value chain. DCAT has been providing a life-long collegial community for its Member Companies, and their representatives, for over 130 years. DCAT helps build relationships within its unique member company profile that includes the Bio/Pharmaceutical industry’s entire manufacturing value chain. DCAT creates objective, expert-driven education programs and informational services so its Member Companies can easily gain insight into … Type: | 6 | 0 | 6 | 35 |
 | HealthCare Institute of New Jersey (HINJ) Advancing Global Health - Leading New Jersey's Economy The HealthCare Institute of New Jersey (HINJ) serves as the voice for the research-based biopharmaceutical and medical technology industry in New Jersey. HINJ seeks to expand patient access to the most innovative biopharmaceuticals, medical technologies and devices, and diagnostics tools and promote awareness of the industry’s impact on New Jersey’s quality of life and economic well-being. Please visit www.hinj.org or follow us on Twitter @ HINJ_ORG, Facebook @ HealthCareInstituteofNewJersey and LinkedIn @HealthCareInstituteOfNewJersey. To learn more about the Life Sciences’ significant impact on New Jersey’s economy, please visit New Jersey’s Life Sciences: By … Type: | 6 | 0 | 7 | 7 |
 | Bayer G4A Changing the Experience of Health G4A is Bayer’s digital health partnerships and investments team dedicated to scaling digital health companies in order to create impact and change the experience of health. Our team’s vision is to reach health for all through digital health. To attain this goal we are working together with like-minded start-ups, digital health companies, government, investors, and strategic partners to offer early stage start-up investments as well as commercial partnerships and late stage investments. Type: | 6 | 2 | 1 | 18 |
 | STADA Group As STADA, we follow our purpose of "Caring for People’s Health as a Trusted Partner". In pursuit of this purpose, we are committed to further accelerating the successful trajectory of our company. STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for 125 years. With our products we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop personally. STADA … Type: | 6 | 2 | 0 | 5,573 |
 | Catalent Pharma Solutions more products. better treatments. reliably supplied. TM Catalent Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent supports our partners in introducing 200 new products and manufacturing over 70 billion doses each year. Since becoming a publicly traded company in 2014, we have grown … Type: | 6 | 6 | 0 | 13,864 |
 | La Coopérative Welcoop [Automatic translation follows] The Welcoop Cooperative is a unique professional community, a true laboratory of ideas, services and solutions in the service of health. Founded in 1935 in Nancy, a cooperative of pharmacists, La Coopérative Welcoop is today a major healthcare player in France, with activities in Europe and Hong Kong. Its ambition is to provide concrete solutions to major public health challenges, by synergising the group's expertise and innovations at the service of all health professionals, with one and the same objective: working for health and well-being. -be patient and make the health system more efficient. The Cooperative has … Type: | 6 | 1 | 5 | 751 |
 | SynapCell We identify your most effective drug candidates in vivo with objective and translational measures within the brain. #EEG SynapCell is a Brain-focused biotechnology company that provides drug developers with robust and unbiased endpoints on drug efficacy in vivo, at the preclinical step. We use quantitative, EEG-based methods to longitudinally monitor a drug effect on translational models, following clinical-like protocols. Our capabilities include dose-response studies, pharmacodynamics, biomarker identification and modulation, disease-modifying assays, model phenotyping, as well as phenotypic screening for lead selection and validation. Our expertise in Neuroscience covers Epilepsy, Parkinson's disease, Essential Tremors as well as information processing defects such … Type: | 6 | 4 | 3 | 37 |
 | Kayentis Simplify your clinical trial experience Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company … Type: | 6 | 5 | 2 | 164 |
 | PharmaVie [Automatic translation follows] Our well-being. Your well-being. NETWORK OF INDEPENDENT PHARMACISTS UNDER BRAND Private Label Branded products ISOMED our branded generic range Commercial dynamism Brand marketing Price policy Training NUTRITHERAPY The sign is an important visual identification for the pharmacist who must now group together in view of the economic changes in the pharmacy (OTC, drop in margins, CAP, etc.) Pharmaceutical industry, Parapharmacy, and Pharmacy | 6 | 1 | 2 | 108 |
 | Genoscience Pharma Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule Type: | 6 | 2 | 4 | 8 |
 | Provepharm Act to improve life An independent, international specialty pharmaceutical company, Provepharm leverages the potential of mature and well-known molecules to develop innovative solutions that improve patients' lives. Provepharm develops, manufactures, and markets a range of hospital products including antidotes and dyes. Notably, the company is recognized for its expertise in the endoscopic and surgical dye markets. Working closely with healthcare professionals, Provepharm is committed to developing specific services aimed at helping them enhance clinical practices. With a team of over 160 professionals and offices in France, the US and UK, the company markets its products in over 25 countries worldwide … Type: | 6 | 4 | 2 | 154 |
 | ALBHADES [Automatic translation follows] Analytical Solutions for Health Products 💊💉 Expert in microbiology and physico-chemistry, Albades has been supporting the health product industries (pharmaceuticals, medical devices, cosmetics), the chemical and food industries since 2001. Its analytical capabilities combined with its consulting service offer a global solution to the needs of method development and validation, process validation and quality control of raw materials, finished products and packaging. Its multiple combination of expertise positions Albhades with a complete analytical offering including inorganic chemistry, organic chemistry, NMR analyses, microbiology, cellular biology, mechanical testing, stability studies and toxicology. Its strength lies in the personalized support … Type: | 6 | 1 | 3 | 69 |
 | PhinC Development 15 ans de modélisation en pharmacologie appliquée au développement des candidats-médicaments PhinC Development is the PK Modeling & Simulation partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research. Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development. Our mission consists in developing the best models to take advantage of all the research data at every phase (in vitro, in vivo animal and human) and carry out robust simulations and predictions requested and recommended by the regulatory authorities … Type: | 6 | 2 | 5 | 15 |
 | LEO Pharma France [Automatic translation follows] LEO Pharma helps patients have healthy skin. By offering therapeutic solutions in more than 100 countries around the world, LEO Pharma helps people manage their skin problems. Founded in 1908, the pharmaceutical company is fully owned by the LEO Foundation. For decades, LEO Pharma has dedicated its research and development to medicines and solutions for people suffering from skin diseases. The parent company of LEO Pharma is based in Denmark and has around 5,000 employees worldwide. For more information, go to www.leo-pharma.com and www.leo-pharma.fr Dermatology, Thrombosis, Psoriasis, and Atopic Dermatitis Type: | 6 | 2 | 3 | 187 |
 | ILYA Pharma Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients ATMP, Gene Therapy, Biologics, Drug development, Clinical trials, GMP, Growth, H2020, Uppsala, IBD, Wound treatment, Scar, Topical, Oral, Research, Science, Immunology, Immunophysiology, microbiology, Applied microbiology, Regulatory excellence, Skin, Diabetes, Cutting edge, and IBD Type: | 6 | 0 | 4 | 15 |
 | Medsii.com Medsii.com is a UK B2B HealthTech Delivering Regulatory-Grade Medicines Intelligence Faster. Medsii.com is the flagship product of PharmaSentinel, a UK B2B HealthTech Providing Targeted Medicines Intelligence for Pharmaceuticals, Biotechs, Clinicians and Industry Analysts. Our flagship app Medsii.com (also on the App Store & Play Store) leverages AI to offer more accurate and more efficient information management, giving our customers a competitive edge. Our solution is already being used by leading pharmaceutical companies. #Pharmaceuticals #Medicines #RegulatoryInformation #ClinicalInformation #DigitalSolutions HealthTech, Digital Health, Startup, and AI Type: | 6 | 0 | 6 | 1 |
 | Advarra Advancing clinical research: safer, smarter, faster Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted IRB and IBC review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster. For more information, visit advarra.com. Central IRB, Human Subject Protection, IRB Services, Clinical Research, Independent IRB, Institutional Review Board, Ethics Review, … Type: | 6 | 0 | 5 | 1,442 |
 | Debiopharm we develop for patients Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university … Type: | 6 | 4 | 3 | 494 |
 | Vaxxel The future of vaccines against respiratory infections. Vaxxel develops novel and proprietary live-attenuated vaccines candidate against bronchiolitis and pneumonia and in particular against human Metnapneumovirus and against human Respiratory Virus. Vaxxel is a spin off fom Virpath, the virology and human pathology Laboratory of the University Claude Bernard in Lyon (UCBL), France, and has been founded by Dr. Manuel Rosa-Calatrava Co-Director of Virpath (Lyon), Pr. Guy Boivin of the University of Laval (Quebec), by Denis Cavert, President of Vaxxel. recherche-développement, biotechnologies, santé, and vaccin Type: | 6 | 0 | 6 | 11 |
 | ApconiX Nonclinical safety experts asking the right questions at the right time to make safer, more effective drugs ApconiX was formed by three AstraZeneca colleagues with the drive and ambition to create a world-renowned company known for its expertise in nonclinical safety toxicology and ion channel electrophysiology. The company is founded on the skills and experience of a growing team with a wide range of expertise in preclinical drug safety. The model for the pharmaceutical industry has evolved in recent years with large pharma reducing internal capability and outsourcing key skills to trusted partners. There are many more SMEs who also … Type: | 6 | 0 | 6 | 51 |
 | pharma.be pharma.be is the federation of 130+ innovative pharmaceutical companies active in Belgium. pharma.be, the federation of the innovative biopharmaceutical industry in Belgium, represents over 128 companies and 42.000 employees active in human healthcare in Belgium. As a full partner of physicians, pharmacists, hospitals, governments and other stakeholders, pharma.be has the mission to promote better health care through therapeutic innovation in the domain of medicinal products for human and veterinary use. Therefore, the top priority is to ensure that patients have the fastest possible access to innovative medicines resulting from research and development. Twitter: https://twitter.com/pharmabe and @CarolineVen Website: www.pharma.be Pharmaceutical industry Type: | 6 | 1 | 6 | 50 |
 | Alentis Therapeutics We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis Alentis Therapeutics, the Claudin-1 (CLDN1) company, is a clinical stage biotechnology company on a mission to develop first-in-class antibodies and ADCs for CLDN1+ tumors and organ fibrosis. Alentis is pioneering a novel approach to modify and reverse the course of disease progression targeting CLDN1, a previously unexploited target that plays a key role in the pathology of tumors and fibrotic diseases across multiple organs. Alentis is the only company developing potential treatments for solid cancers and fibrosis targeting CLDN1. Alentis’ portfolio of anti-CLDN1 monoclonal antibodies includes a novel class of … Type: | 6 | 0 | 0 | 59 |
 | C4X Discovery Ltd Pioneering drug discovery company exploiting cutting edge technologies to create best-in-class small molecule medicines C4X Discovery aims to become the world's most productive drug discovery engine by exploiting cutting edge technologies to design and create best-in-class small-molecule candidates targeting a range of high value therapeutic areas. The company's goal is to drive returns through early-stage revenue-generating deals with the pharmaceutical industry. C4X Discovery has a state-of-the-art suite of proprietary technologies across the drug discovery process. The company's innovative DNA-based target identification platform (Taxonomy3(R)) utilises human genetic datasets to identify novel patient-specific targets leading to greater discovery productivity and increased probability … Type: | 7 | 1 | 4 | 46 |
 | Proteus Digital Health, Inc Healthcare for everyone, everywhere. Welcome to Proteus Digital Health, a leading innovator spearheading the Digital Medicines revolution. Join our unique collection of innovative engineers, scientists, designers, developers, clinicians, and other digital health pioneers, and assist us with achieving our compelling vision, “Healthcare for Everyone, Everywhere.” Proteus is creating a new category of pharmaceuticals: Digital Medicines. Digital Medicine includes drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making, and data analytics to serve the needs of doctors and health systems. The goal of Digital Medicine is to empower … Type: | 7 | 1 | 0 | 66 |
 | SIMV [Automatic translation follows] The SIMV represents companies in medicines, diagnostics, devices and technologies for animal health The SIMV represents companies which manufacture and place on the French market medicines and diagnostics intended for companion and farm animals. It is the DNA common to our entire industry, at the heart of many interactions. In order to contribute to the competitiveness of its member companies, the SIMV, which has 41 laboratories, defines its value creation through its professions: • Federate companies around common projects, • Anticipate, in order to propose collective strategies in response to society's expectations (strategic monitoring), • Advise/train/inform its … Type: | 7 | 2 | 5 | 12 |
 | Egualia – Industrie Farmaci Accessibili A better future. For everyone. Egualia (formerly Assogenerici) is the Italian Federation of Industries for Accessible Medicines which today represents more than fifty companies, over 95% of the companies producing generic, biosimilar and value-added medicines. Founded in 1993, it is a member of the European association of the sector, Medicines for Europe, and welcomes multinational and Italian companies present throughout the territory, which produce both for the domestic and foreign markets, as well as companies engaged in the production of drugs on behalf of third parties for the entire pharmaceutical industry. Generics and biosimilars cover 80% of therapeutic areas and … Type: | 7 | 0 | 7 | 18 |
 | TrialCard TrialCard is now Mercalis. Please follow our new LinkedIn page: https://www.linkedin.com/company/mercalisinc TrialCard became Mercalis on September 20, 2023. Mercalis is an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company partners closely with its clients to deliver an end-to-end spectrum of commercial capabilities that work together seamlessly and flexibly. Backed by proven industry expertise and results-driven technology, Mercalis provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Above all, Mercalis helps navigate the complex life sciences marketplace … Type: | 7 | 0 | 7 | 680 |
 | CHPA CHPA is the 141-year-old national trade association representing the leading manufacturers and marketers of OTC meds. Founded in 1881, the Consumer Healthcare Products Association (CHPA) is the national trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $7.33, contributing a total of $167 billion in savings each year. CHPA is committed to promoting the increasingly vital role of OTC medicines and dietary supplements in America’s healthcare system through science, education, and advocacy. Visit www.chpa.org to learn more. Over-the-counter … Type: | 7 | 0 | 7 | 124 |
 | Guerbet At Guerbet, we build lasting relationships so that we enable people to live better. This is our Purpose. At Guerbet, we build lasting relationships so that we enable people to live better. This is our Purpose. We place human cooperation at the heart of our relationships and actions. We are a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging. A pioneer since 95 years in the field of contrast media, we are a team of over 2,600 people globally, continuously innovating with 10% of revenue … Type: | 7 | 2 | 1 | 2,412 |
 | Recipharm Your innovation, delivered with certainty. Recipharm is an experienced, global CDMO dedicated to meeting pharmaceutical companies’ evolving needs through operational excellence, scientific know-how and customer connectivity. Headquartered in Stockholm, Sweden, we operate development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and are continuing to grow and expand our offering. Our worldwide reach paired with in-depth, localised market knowledge allows us to anticipate our customers’ needs and strengthen the support we provide to forge a healthier, more expansive and more fruitful future together. With a workforce of approximately 9,000 people, we … Type: | 7 | 3 | 0 | 3,526 |
 | Texcell Expert in viral safety since 1987. Texcell is a dedicated partner for biotechnology and pharmaceutical companies since more than 2 decades. Thanks to an unique combination of expertise in Virology and Immunology, we can provide a full support to your product development from the proof of concept to clinical studies and GMP manufacturing. Our state-of the Art facilities are located in France, Germany and in the US where we use most recent technologies to efficiently perform a wide range of assays What do we provide ? A specialized analytical lab for your preclinical and clinical studies, including: - Cell based … Type: | 7 | 0 | 7 | 112 |
 | ROVI Pharmaceutical Company Investigamos para crecer en salud. Laboratorios Farmacéuticos ROVI, S.A. is a chemical and pharmaceutical company incorporated in Madrid in 1946 and its activities concentrate on its own pharmaceutical products, manufacturing for third parties and distribution of other products for which it holds a licence from other laboratories devoting all its efforts to the satisfaction of its internal and external clients for the promotion of health within Society. ROVI ́s dedication and its strategy of encouraging the international trade, has led to extend Bemiparin presence, whether in pre-registration, registration or marketing stage, to a total of 88 countries thanks to the … Type: | 7 | 1 | 4 | 1,060 |
 | Cipla Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality … Type: | 7 | 2 | 1 | 41,185 |
 | MSD Animal Health – Swine Team As a global healthcare leader, MSD works to help the world be well. As a global healthcare leader, MSD works to help the world be well. MSD Animal Health is the global animal health business unit of MSD. We offer one of the industry’s most innovative portfolios to prevent, treat and control diseases across all major farm and companion animal species. Our mission – The Science of Healthier Animals – guides all of our work. Healthier animals mean a sustainable food supply and protection for humans against diseases passed from animals. Our products fight diseases that can devastate swine herds, … Type: | 7 | 0 | 4 | 40 |
 | Sanofi Polska [Automatic translation follows] We chase the miracles of science to improve people's lives. Sanofi is an innovative, global biopharmaceutical company with one goal: to change the world for the better, in accordance with the slogan "We chase the miracles of science to improve people's lives", relying on the power of science. In 100 countries, committed and talented teams are working to change the face of medicine, making the impossible possible. The company creates therapies and vaccines that save the lives of millions of people around the world. We have a wide range of specialized medicinal products and services in many … Type: | 7 | 0 | 7 | 173 |
 | MSD España [Automatic translation follows] We invent for life! At MSD - known as Merck & Co., Inc. in the United States and Canada, headquartered in Rahway, New Jersey - we are united by our purpose of harnessing the potential of science to save and improve lives around the world. For more than 130 years, we have provided hope through the development of important medicines and vaccines. We aspire to be the world's leading biopharmaceutical research company and are currently at the forefront of research into innovative health solutions to advance the prevention and treatment of human and animal diseases. We foster … Type: | 7 | 1 | 2 | 374 |
 | Organon France [Automatic translation follows] Official page of Organon France. Improving the health of every woman and making every day a better day. International pharmaceutical laboratory, leader in women's health and major player in the provision of biosimilar drugs and historic drugs with high public health issues. For more information, go to www.organon.fr or follow us on https://twitter.com/OrganonFrance To contact our medical information service: ☎️ 01 57 77 32 00 📩 info.medicale.fr@organon.com Type: | 7 | 2 | 6 | 117 |
 | SGD Pharma Pharmaceutical Glass Packaging Solutions SGD Pharma has unique know-how and offers innovative premium quality primary packaging compliant with international pharmacopoeias. From design to manufacturing, our teams will support you in the development and implementation of your project. SGD Pharma’s corporate quality policy is applied in all of its manufacturing facilities and is compliant with pharmaceutical Good Manufacturing Practices (GMPs). Recognizing that the patient is the end user of its products, SGD Pharma implements the strictest quality standards. All of our manufacturing sites are fully dedicated to pharmacy and are according to ISO 15378 standards. Each of our vials is inspected … Type: | 7 | 1 | 6 | 1,071 |
 | Kymos Analytical CRO devoted to bioanalysis and quality control of small molecules, biologics and nucleic acids Kymos is a CRO that provides development services for pharmaceutical, biotechnology, veterinary, fine chemistry, cosmetics and nutraceuticals industries. The main areas of activity are the following ones: i) Immunogenicity studies and immunoassay of innovative biological drugs, biosimilars and vaccines. ii) Bioanalysis in preclinical and clinical studies, including full bioequivalence studies. iii) Quality control, stability studies and analytical development of drug substances and drug products (physico-chemical and microbiological testing) iv) Process analytical technology services, using NIR and RAMAN and QbD strategies. Kymos is certified in GLP's … Type: | 7 | 1 | 0 | 165 |
 | MSD Deutschland [Automatic translation follows] Inventing for life. At MSD, known in the US and Canada as Merck & Co., Inc., Rahway, NJ, USA, we are united by one goal: We use leading scientific findings to save lives and enable a better quality of life around the world. We have been representing progress through the development of important new medications and vaccines for over 130 years. Our aim is to be a global leader as a research-based biopharmaceutical company - and we develop innovative health solutions and active ingredients that further improve the prevention and treatment of diseases in humans and animals. … Type: | 7 | 1 | 6 | 1,953 |
 | Chiesi France [Automatic translation follows] Taking care of patients and the planet today for tomorrow! CHIESI is an Italian family biopharmaceutical group offering innovative therapeutic solutions to patients in 3 therapeutic areas: AIR (products and solutions for respiratory diseases from newborns to adults), RARE (treatments for rare and ultra-rare diseases) , CARE (products and services in kidney and liver transplantation and prevention, in micronutrition) Bringing together nearly 6,500 employees worldwide, CHIESI is present in France across the entire value added chain – R&D, production, distribution and provision to healthcare professionals and patients – with a figure of business reaching nearly €175 million … Type: | 7 | 3 | 4 | 316 |
 | Daiichi Sankyo, Inc. We create life-changing solutions for patients. At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solutions for the patients of today and tomorrow with great care and unwavering dedication. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.us. See our community guidelines here: https://bit.ly/3PYTqYr Daiichi Sankyo, Inc. … Type: | 7 | 1 | 5 | 4,109 |
 | Diversity Alliance for Science The LIFE SCIENCE/ HEALTHCARE Organization to get involved in! Since 2008, Diversity Alliance for Science has been the pre-eminent networking organization for life science companies and diverse-certified suppliers to connect, collaborate and drive the value of diversity. Our networking events are about genuine connections and finding the best way to spark innovation through building business relationships on our diverse perspectives. Our suppliers and corporations build their bottom lines by keeping our shared goals in mind: all the work they produce contributes to making medicines, devices, and ideas that save lives. The best way to get to know our organization is … Type: | 7 | 0 | 7 | 10 |
 | Medrise Studio Driving healthcare's digital evolution with Web3. Driving healthcare's digital evolution with Web3. From the genesis block to groundbreaking solutions, we're your bridge to the decentralized era. blockchain, digital health, pharmaceuticals, consulting, technology, artificial intelligence, and patients Type: | 8 | 1 | 4 | 5 |
 | Mayoly [Automatic translation follows] Taking care to heart Through its subsidiaries, Mayoly is a family-owned, independent, French pharmaceutical and dermatological laboratory with an international footprint. For more than a century, it has successfully been growing its business with a focus on Gastroenterology and Dermocosmetics. Our French industrial heritage relates to our values of Responsibility, Pragmatism and Caring. We strive passionately and tirelessly to provide patients and people with the best possible healthcare daily, and aim to establish ourselves as a leader in Consumer Healthcare over the coming decades Our know-how applies to several therapeutic areas, such as gastroenterology, rheumatology, ENT, general … Type: | 8 | 1 | 2 | 878 |
 | Pharmacy Quality Alliance Optimizing health by advancing the quality of medication use Optimizing Health by Advancing the Quality of Medication Use. quality measures, measure development, medication use, and medication safety Type: | 8 | 0 | 8 | 47 |
 | Excelya Expertly delivering clinical trials operations, with care. Excelya is an independent partner that serves Biotech, Pharma, and Medical Device organizations with a comprehensive range of Full-service CRO, FSP, and Resourcing solutions guided by compassion, care, and excellence. Founded in 2014 and headquartered in Paris, France, and operating in 28 countries across Europe, USA and India, Excelya has a global team of 900+ experts who understand the critical needs of clients to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas, with speciality focus on Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, … Type: | 8 | 2 | 3 | 702 |
 | Innovative Medicines Canada - Médicaments novateurs Canada The voice of Canada’s research-based pharmaceutical sector. Canada’s innovative pharmaceutical companies have never shied away from doing whatever it takes — because it is worth it to provide hope to people when they need it most. We work hard to help improve and extend the lives of Canadians. Type: | 8 | 2 | 6 | 41 |
 | British Pharmacological Society Today's Science, Tomorrow's Medicines The British Pharmacological Society is a charity with a mission to promote and advance the whole spectrum of pharmacology. Founded in 1931, the Society now leads the way in the research and application of pharmacology around the world. It is a global membership community at the heart of pharmacology, with nearly 4,500 members from more than 60 countries worldwide. It supports pharmacologists with their education, careers, networking, meetings, research, funding, engagement, training, policy and journals and publishing. pharmaceutials, pharmacology, clinical pharmacology, education, careers, funding, networking, journals, publishing, engagement, training, and policy Type: | 8 | 2 | 6 | 179 |
 | OPPI India Partnering India since pre-independence to improve patient safety & provide healthcare access to all. #BharatKeLiye The Organisation of Pharmaceutical Producers of India (OPPI) was established in 1965 and represents the research-based pharmaceutical companies in India. OPPI remains committed to supporting the nation’s healthcare objectives and collaborating with all stakeholders to find sustainable solutions. OPPI believes the need for innovation must be balanced with the necessity for more accessible medicines, within a robust IP environment. Vision: OPPI is an organisation of research and innovation driven pharmaceutical companies committed to addressing India's healthcare needs by: - Facilitating greater access to quality healthcare … Type: | 8 | 1 | 8 | 15 |
 | CQDM Facilitateur d'innovation biopharma // Facilitator of biopharma innovation Facilitator of biopharma innovation // Facilitateur d'innovation biopharma. CQDM is a pharma-based consortium active in biopharmaceutical research. Our mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM receives financial support from pharmaceutical companies Amgen, AstraZeneca, GSK, Merck, Pfizer, Roche, Sanofi, Servier, Takeda as well as from Quebec’s Ministère de l'Économie, l'Innovation et de l'Énergie (MEIE). For more information: www.cqdm.org. Le CQDM est un consortium pharmaceutique actif … Type: | 8 | 2 | 8 | 30 |
 | BIOGARAN [Automatic translation follows] The box that takes care of you. French drug laboratory 🇫🇷 Biogaran was founded in 1996, to specifically respond to the development of a new, still little-known market: generic medicines. Offering patients quality medicines with recognized effectiveness whose patent has fallen into the public domain then required a new type of know-how that traditional laboratories did not possess. Our know-how is available through different ranges: from minor everyday ailments with the Biogaran Conseil® range, to more serious pathologies with prescription medications. Whatever the pathology, patient health is at the heart of Biogaran's concerns and the same rigor … Type: | 8 | 2 | 4 | 511 |
 | Fresenius Kabi FR [Automatic translation follows] Fresenius Kabi is a global healthcare company specializing in life-saving medicines and medical devices in infusion, transfusion and clinical nutrition. Fresenius Kabi's medicines, technologies and services are used to help care for patients in emergency situations or with chronic illnesses. Fresenius Kabi's product portfolio includes a full range of generic intravenous medications, infusion therapies, clinical nutrition products as well as the medical devices required to administer these products. In the biosimilars space, we focus on autoimmune diseases and oncology. In 2019, Fresenius Kabi's first biosimilar product was launched. In the field of transfusion medicine and cell therapies, … Type: | 8 | 1 | 7 | 447 |
 | Alira Health Where Empathy Meets Science to Accelerate Life Sciences Research Alira Health is a global healthcare firm whose mission is to humanize healthcare and life sciences in partnership with patients. From development to medical care, we complement the expertise of our Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle, including clinical operations, real-world evidence, and patient-centric technology offerings. Our integrated and multidisciplinary team of over 800 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50 MedTech companies and 75% of … Type: | 8 | 1 | 2 | 619 |
 | Seratec [Automatic translation follows] Your CDMO for API solutions since 1970 | Our excellence, your trust #OEYT At Seratec, APIs are more than a science. They are a passion. Entrepreneurs in pharmaceutical chemistry since 1970, we produce active pharmaceutical ingredients (APIs) for the treatment of rare and orphan diseases. Drawing on internationally recognized French know-how, we design, develop, produce and register files of pharmacologically active molecules. with the American (FDA), European (EMA) and national (ANSM) drug agencies. To offer the best services, we also ensure the production of APIs according to quality standards known as Good Manufacturing Practices (GMP 2 or … Type: | 8 | 0 | 8 | 25 |
 | CYBERNANO Optimize your product development, Quality by Design for all ! CYBERNANO aims to support pharmaceutical, biotech and medtech companies in the Quality-by-Design (QbD) process. The use of QbD is necessary in these high accuracy industries to predict and avoid risks from the early stage of an innovant project. In order to democratize the QbD approach, which requires a lot of effort and expertise, CYBERNANO offers a QbD semi-automated* SaaS platform : « easyQBD ». *(an expert perspective combined to the efficacy of the platform) CYBERNANO a pour vocation d’accompagner les entreprises des secteurs pharmaceutiques, biotechnologiques et des technologies médicales dans … Type: | 8 | 0 | 7 | 6 |
 | Tufts Center for the Study of Drug Development An Independent, Academic, Non-profit Research Center at Tufts University School of Medicine in Boston, Massachusetts. Our Mission The Tufts Center for the Study of Drug Development is an independent, academic, non-profit research group at Tufts University in Boston, Massachusetts. Our mission is to develop strategic information to help drug developers, regulators, and policy makers improve the quality and efficiency of pharmaceutical and biopharmaceutical development, review, and utilization. Our path-breaking research informs the research-based industry, regulatory agencies, and the public about the nature and pace of pharmaceutical development Our Objectives * To monitor and report on the development, regulation, and utilization … Type: | 8 | 1 | 3 | 36 |
SMB